HAL vs RANI · P/E 9.3, $19.05B cap vs rev $1.0M
Halliburton Company (HAL) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported RANI revenue for 2024-12-31 was $1.0M. Net income was -$56.6M. RANI currently screens at market cap $41.5M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. RANI currently screens at market cap $41.5M.
Not investment advice. Open the HAL and RANI stock pages for the full models.
Not investment advice.